APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,782,893 | +77.1% | 173,248 | +28.2% | 0.62% | +82.3% |
Q1 2023 | $8,912,779 | +159.5% | 135,124 | +103.4% | 0.34% | +160.8% |
Q4 2022 | $3,434,888 | -81.1% | 66,426 | -75.0% | 0.13% | -82.5% |
Q3 2022 | $18,173,000 | +28.7% | 266,076 | -14.8% | 0.74% | +34.1% |
Q2 2022 | $14,117,000 | +41.9% | 312,192 | +59.4% | 0.56% | +59.0% |
Q1 2022 | $9,950,000 | +7.5% | 195,820 | 0.0% | 0.35% | +17.1% |
Q4 2021 | $9,258,000 | +43.4% | 195,820 | 0.0% | 0.30% | +43.3% |
Q3 2021 | $6,454,000 | -33.0% | 195,820 | +28.4% | 0.21% | -33.5% |
Q2 2021 | $9,640,000 | +47.3% | 152,538 | 0.0% | 0.31% | +39.1% |
Q1 2021 | $6,545,000 | -47.0% | 152,538 | -29.4% | 0.22% | -48.2% |
Q4 2020 | $12,356,000 | +89.6% | 216,017 | 0.0% | 0.43% | +77.9% |
Q3 2020 | $6,517,000 | +15.0% | 216,017 | +24.5% | 0.24% | +13.0% |
Q2 2020 | $5,666,000 | +21.9% | 173,494 | 0.0% | 0.22% | +2.9% |
Q1 2020 | $4,648,000 | +15.9% | 173,494 | +32.4% | 0.21% | +38.2% |
Q4 2019 | $4,011,000 | +68.5% | 130,999 | +32.6% | 0.15% | +46.2% |
Q3 2019 | $2,380,000 | – | 98,784 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |